TY - JOUR
T1 - Relation of Dyspnea in Patients Unable to Perform Exercise Stress Testing to Outcome and Myocardial Ischemia
AU - Bernheim, Alain M.
AU - Kittipovanonth, Maytinee
AU - Scott, Christopher G.
AU - McCully, Robert B.
AU - Tsang, Teresa S.
AU - Pellikka, Patricia A.
N1 - Funding Information:
Dr. Bernheim was supported by grants from the Swiss National Science Foundation, Zurich, and the Freiwillige Akademische Gesellschaft Basel, Switzerland. Dr. Kittipovanonth was supported by grants from Siriraj Hospital, Mahidol University, Bangkok, Thailand. The study was supported by a grant from the Mayo Foundation, Rochester, Minnesota.
Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.
PY - 2009/7/15
Y1 - 2009/7/15
N2 - Limited information exists regarding the significance of dyspnea in patients who are unable to exercise and the contribution of myocardial ischemia to this symptom. To assess this, we evaluated results of dobutamine stress echocardiography (DSE) and long-term outcome of patients with dyspnea referred for DSE. We studied 6,376 consecutive patients who were unable to perform an exercise test and were referred for DSE. Patients were classified according to presenting symptoms and followed for 5.5 ± 2.8 years. End points were cardiac ischemic events (myocardial infarction or revascularization), hospitalization for heart failure (HF), and death. Dobutamine stress echocardiogram was positive for ischemia in 19% of patients with dyspnea versus 24% (p = 0.002) of those with typical angina and 17% (p = 0.2) of asymptomatic patients. In multivariate analysis, risk of death was increased in dyspneic patients versus asymptomatic patients (hazard ratio [HR] 1.14, p = 0.02) and patients with chest pain (HR 1.20, p <0.001). Hospitalization for HF occurred more often in patients with dyspnea (HR 1.26, p = 0.05 vs asymptomatic; HR 1.24, p = 0.06 vs chest pain), especially in the subset without previous HF (HR 1.45, p = 0.006 vs chest pain). Risk of cardiac ischemic events in patients with dyspnea was similar versus asymptomatic patients (HR 0.92, p = 0.39) and decreased versus patients with chest pain (HR 0.70, p <0.001). In conclusion, in patients referred for DSE, dyspnea was associated with a poor outcome. This increased hazard seems not to be linked to myocardial ischemia, but instead to HF and death.
AB - Limited information exists regarding the significance of dyspnea in patients who are unable to exercise and the contribution of myocardial ischemia to this symptom. To assess this, we evaluated results of dobutamine stress echocardiography (DSE) and long-term outcome of patients with dyspnea referred for DSE. We studied 6,376 consecutive patients who were unable to perform an exercise test and were referred for DSE. Patients were classified according to presenting symptoms and followed for 5.5 ± 2.8 years. End points were cardiac ischemic events (myocardial infarction or revascularization), hospitalization for heart failure (HF), and death. Dobutamine stress echocardiogram was positive for ischemia in 19% of patients with dyspnea versus 24% (p = 0.002) of those with typical angina and 17% (p = 0.2) of asymptomatic patients. In multivariate analysis, risk of death was increased in dyspneic patients versus asymptomatic patients (hazard ratio [HR] 1.14, p = 0.02) and patients with chest pain (HR 1.20, p <0.001). Hospitalization for HF occurred more often in patients with dyspnea (HR 1.26, p = 0.05 vs asymptomatic; HR 1.24, p = 0.06 vs chest pain), especially in the subset without previous HF (HR 1.45, p = 0.006 vs chest pain). Risk of cardiac ischemic events in patients with dyspnea was similar versus asymptomatic patients (HR 0.92, p = 0.39) and decreased versus patients with chest pain (HR 0.70, p <0.001). In conclusion, in patients referred for DSE, dyspnea was associated with a poor outcome. This increased hazard seems not to be linked to myocardial ischemia, but instead to HF and death.
UR - http://www.scopus.com/inward/record.url?scp=67649336447&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67649336447&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2009.03.028
DO - 10.1016/j.amjcard.2009.03.028
M3 - Article
C2 - 19576358
AN - SCOPUS:67649336447
SN - 0002-9149
VL - 104
SP - 265
EP - 269
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 2
ER -